Compounds > n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide
Page last updated: 2024-10-28

n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide and Leukemia, Myeloid, Acute

n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide has been researched along with Leukemia, Myeloid, Acute in 1 studies

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, S1
Kubota, M1
Lin, YW1
Okuda, A1
Matsubara, K1
Wakazono, Y1
Hirota, H1
Kuwakado, K1
Akiyama, Y1

Trials

1 trial available for n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide and Leukemia, Myeloid, Acute

ArticleYear
In vivo administration of granulocyte colony-stimulating factor promotes neutrophil survival in vitro.
    European journal of haematology, 1994, Volume: 53, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adolescent; Burkitt Lymphoma; Cell Survival; Child; C

1994